These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 23057994)

  • 21. Myocardial dysfunction in long-term breast cancer survivors treated at ages 40-50 years.
    Jacobse JN; Steggink LC; Sonke GS; Schaapveld M; Hummel YM; Steenbruggen TG; Lefrandt JD; Nuver J; Crijns APG; Aleman BMP; van der Meer P; Gietema JA; van Leeuwen FE
    Eur J Heart Fail; 2020 Feb; 22(2):338-346. PubMed ID: 31696625
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impaired exercise capacity and left ventricular function in long-term adult survivors of childhood acute lymphoblastic leukemia.
    Christiansen JR; Kanellopoulos A; Lund MB; Massey R; Dalen H; Kiserud CE; Ruud E; Aakhus S
    Pediatr Blood Cancer; 2015 Aug; 62(8):1437-43. PubMed ID: 25832752
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiac function in survivors of acute lymphoblastic leukaemia and Hodgkin's lymphoma.
    Krawczuk-Rybak M; Dakowicz L; Hryniewicz A; Maksymiuk A; Zelazowska-Rutkowska B; Wysocka J
    J Paediatr Child Health; 2011 Jul; 47(7):455-9. PubMed ID: 21332587
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Screening for cardiac dysfunction in anthracycline-exposed childhood cancer survivors.
    Armenian SH; Gelehrter SK; Vase T; Venkatramani R; Landier W; Wilson KD; Herrera C; Reichman L; Menteer JD; Mascarenhas L; Freyer DR; Venkataraman K; Bhatia S
    Clin Cancer Res; 2014 Dec; 20(24):6314-23. PubMed ID: 24947931
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Subclinical anthracycline-induced cardiotoxicity in long-term follow-up of asymptomatic childhood cancer survivors: Assessment by speckle tracking echocardiography.
    Çetin S; Babaoğlu K; Başar EZ; Deveci M; Çorapçıoğlu F
    Echocardiography; 2018 Feb; 35(2):234-240. PubMed ID: 29106752
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Myocardial performance index and biochemical markers for early detection of doxorubicin-induced cardiotoxicity in children with acute lymphoblastic leukaemia.
    Ruggiero A; De Rosa G; Rizzo D; Leo A; Maurizi P; De Nisco A; Vendittelli F; Zuppi C; Mordente A; Riccardi R
    Int J Clin Oncol; 2013 Oct; 18(5):927-33. PubMed ID: 22911020
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low anthracyclines doses-induced cardiotoxicity in acute lymphoblastic leukemia long-term female survivors.
    Amigoni M; Giannattasio C; Fraschini D; Galbiati M; Capra AC; Madotto F; Cesana F; Jankovic M; Masera G; Mancia G
    Pediatr Blood Cancer; 2010 Dec; 55(7):1343-7. PubMed ID: 20589666
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Right ventricular function in long-term adult survivors of childhood lymphoma and acute lymphoblastic leukaemia.
    Christiansen JR; Massey R; Dalen H; Kanellopoulos A; Hamre H; Ruud E; Kiserud CE; Fosså SD; Aakhus S
    Eur Heart J Cardiovasc Imaging; 2016 Jul; 17(7):735-41. PubMed ID: 26917232
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serial measurements of NT-proBNP are predictive of not-high-dose anthracycline cardiotoxicity in breast cancer patients.
    Romano S; Fratini S; Ricevuto E; Procaccini V; Stifano G; Mancini M; Di Mauro M; Ficorella C; Penco M
    Br J Cancer; 2011 Nov; 105(11):1663-8. PubMed ID: 22068815
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Subclinical Cardiac Dysfunction in Childhood Cancer Survivors on 10-Years Follow-Up Correlates With Cumulative Anthracycline Dose and Is Best Detected by Cardiopulmonary Exercise Testing, Circulating Serum Biomarker, Speckle Tracking Echocardiography, and Tissue Doppler Imaging.
    Wolf CM; Reiner B; Kühn A; Hager A; Müller J; Meierhofer C; Oberhoffer R; Ewert P; Schmid I; Weil J
    Front Pediatr; 2020; 8():123. PubMed ID: 32296665
    [No Abstract]   [Full Text] [Related]  

  • 31. Assessment of echocardiography and biomarkers for the extended prediction of cardiotoxicity in patients treated with anthracyclines, taxanes, and trastuzumab.
    Sawaya H; Sebag IA; Plana JC; Januzzi JL; Ky B; Tan TC; Cohen V; Banchs J; Carver JR; Wiegers SE; Martin RP; Picard MH; Gerszten RE; Halpern EF; Passeri J; Kuter I; Scherrer-Crosbie M
    Circ Cardiovasc Imaging; 2012 Sep; 5(5):596-603. PubMed ID: 22744937
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Values of high sensitive troponin T in long-term survivors of childhood cancer treated with anthracyclines.
    Pourier MS; Kapusta L; van Gennip A; Bökkerink JP; Loonen J; Bellersen L; Mavinkurve-Groothuis AM
    Clin Chim Acta; 2015 Feb; 441():29-32. PubMed ID: 25512165
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiac biomarkers for the detection of cardiotoxicity in childhood cancer-a meta-analysis.
    Michel L; Mincu RI; Mrotzek SM; Korste S; Neudorf U; Rassaf T; Totzeck M
    ESC Heart Fail; 2020 Apr; 7(2):423-433. PubMed ID: 32069386
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biomarkers to diagnose ventricular dysfunction in childhood cancer survivors: a systematic review.
    Leerink JM; Verkleij SJ; Feijen EAM; Mavinkurve-Groothuis AMC; Pourier MS; Ylänen K; Tissing WJE; Louwerens M; van den Heuvel MM; van Dulmen-den Broeder E; de Vries ACH; Ronckers CM; van der Pal HJH; Kapusta L; Loonen J; Bellersen L; Pinto YM; Kremer LCM; Kok WEM
    Heart; 2019 Feb; 105(3):210-216. PubMed ID: 30158136
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exposure to anthracyclines during childhood causes cardiac injury.
    Lipshultz SE
    Semin Oncol; 2006 Jun; 33(3 Suppl 8):S8-14. PubMed ID: 16781284
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardioprotection against the toxic effects of anthracyclines given to children with cancer: a systematic review.
    Bryant J; Picot J; Levitt G; Sullivan I; Baxter L; Clegg A
    Health Technol Assess; 2007 Jul; 11(27):iii, ix-x, 1-84. PubMed ID: 17610809
    [TBL] [Abstract][Full Text] [Related]  

  • 37. N-terminal pro-brain natriuretic peptide (NT-proBNP) serum concentrations in apparently healthy Bosnian women.
    Hadzović-Dzuvo A; Kucukalić-Selimović E; Nakas-Ićindić E; Zaćiragić A; Drazeta Z
    Bosn J Basic Med Sci; 2007 Nov; 7(4):307-10. PubMed ID: 18039187
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of N-terminal pro-brain natriuretic peptide to assess left ventricular function after adjuvant doxorubicin therapy in early breast cancer patients: a prospective series.
    Cil T; Kaplan AM; Altintas A; Akin AM; Alan S; Isikdogan A
    Clin Drug Investig; 2009; 29(2):131-7. PubMed ID: 19133708
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The use of biochemical markers in cardiotoxicity monitoring in patients treated for leukemia.
    Horácek JM; Pudil R; Tichý M; Jebavý L; Strasová A; Praus R; Zák P; Malý J
    Neoplasma; 2005; 52(5):430-4. PubMed ID: 16151589
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The utility of NT-proBNP and various echocardiographic methods in the determination of doxorubicin induced subclinical late cardiotoxicity.
    Yildirim A; Tunaoglu FS; Kambur K; Pinarli FG
    Kardiol Pol; 2013; 71(1):40-6. PubMed ID: 23348532
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.